Pfg Advisors Pfizer Inc Transaction History

Pfg Advisors

$1.45 Billion
Q2 2024

A detailed history of Pfg Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Pfg Advisors holds 21,972 shares of PFE stock, worth $627,740. This represents 0.04% of its overall portfolio holdings.

Number of Shares

21,972

Previous 24,376 9.86%

Holding current value

$627,740

Previous $676,000 9.17%

% of portfolio

0.04%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$25.26 - $29.6 $60,725 - $71,158	-2,404 Reduced 9.86%	21,972 $614,000
Q1 2024 May 06, 2024	SELL	$25.89 - $29.73 $40,724 - $46,765	-1,573 Reduced 6.06%	24,376 $676,000
Q4 2023 Jan 19, 2024	SELL	$26.13 - $33.94 $82,204 - $106,775	-3,146 Reduced 10.81%	25,949 $747,000
Q3 2023 Oct 13, 2023	SELL	$32.09 - $37.51 $524,639 - $613,250	-16,349 Reduced 35.98%	29,095 $965,000
Q2 2023 Jul 20, 2023	SELL	$36.12 - $41.79 $52,590 - $60,846	-1,456 Reduced 3.1%	45,444 $1.67 Million
Q1 2023 Apr 20, 2023	SELL	$39.39 - $51.28 $192,065 - $250,041	-4,876 Reduced 9.42%	46,900 $1.91 Million
Q4 2022 Jan 27, 2023	BUY	$41.75 - $54.5 $205,451 - $268,194	4,921 Added 10.5%	51,776 $2.65 Million
Q3 2022 Oct 13, 2022	SELL	$43.76 - $53.42 $16,935 - $20,673	-387 Reduced 0.82%	46,855 $2.05 Million
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $97,806 - $115,967	2,102 Added 4.66%	47,242 $2.48 Million
Q1 2022 Apr 19, 2022	SELL	$45.75 - $56.69 $10,751 - $13,322	-235 Reduced 0.52%	45,140 $2.34 Million
Q4 2021 Jan 21, 2022	BUY	$41.32 - $61.25 $189,204 - $280,463	4,579 Added 11.22%	45,375 $2.68 Million
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $76,027 - $97,663	-1,937 Reduced 4.53%	40,796 $1.76 Million
Q2 2021 Jul 28, 2021	BUY	$35.91 - $40.68 $73,615 - $83,394	2,050 Added 5.04%	42,733 $1.67 Million
Q1 2021 Apr 27, 2021	BUY	$33.49 - $37.77 $469,630 - $529,648	14,023 Added 52.6%	40,683 $1.47 Million
Q4 2020 Jan 26, 2021	BUY	$33.47 - $42.56 $131,001 - $166,579	3,914 Added 17.21%	26,660 $981,000
Q3 2020 Oct 13, 2020	BUY	$31.75 - $37.25 $15,049 - $17,656	474 Added 2.13%	22,746 $829,000
Q2 2020 Jul 16, 2020	SELL	$30.12 - $36.54 $62,077 - $75,308	-2,061 Reduced 8.47%	22,272 $754,000
Q1 2020 Apr 29, 2020	BUY	$27.03 - $38.62 $58,141 - $83,071	2,151 Added 9.7%	24,333 $878,000
Q4 2019 Jan 14, 2020	BUY	$32.92 - $37.36 $14,846 - $16,849	451 Added 2.08%	22,182 $866,000
Q3 2019 Oct 15, 2019	SELL	$32.49 - $42.13 $1,039 - $1,348	-32 Reduced 0.15%	21,731 $776,000
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $100,030 - $112,311	2,705 Added 14.19%	21,763 $937,000
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $438,412 - $481,669	11,691 Added 158.69%	19,058 $774,000
Q4 2018 Feb 19, 2019	SELL	$38.47 - $43.86 $75,170 - $85,702	-1,954 Reduced 20.96%	7,367 $308,000
Q4 2018 Jan 18, 2019	BUY	$38.47 - $43.86 $103,484 - $117,983	2,690 Added 40.57%	9,321 $404,000
Q3 2018 Oct 26, 2018	SELL	$34.47 - $41.81 $5,687 - $6,898	-165 Reduced 2.43%	6,631 $292,000
Q2 2018 Jul 19, 2018	BUY	$32.98 - $35.16 $9,893 - $10,547	300 Added 4.62%	6,796 $247,000
Q1 2018 Apr 06, 2018	BUY	$31.91 - $37.02 $207,287 - $240,481	6,496 New	6,496 $231,000

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Advisors with notifications on news.

Account